Sanofi’s Hornstein Sees China’s Online Hospitals Boosting Digital Health Strategy
Sanofi’s outgoing China market president, Pius Hornstein, expressed confidence in the potential of China’s online...
Sanofi
Rona Therapeutics Licenses Sanofi’s siRNA Platform for Global Development
Shanghai-based RNA therapeutics specialist Rona Therapeutics has entered into a licensing agreement with French pharmaceutical...
ClouDr Group’s Hong Kong IPO Nets HKD 482 Million with Sanofi as Investor
Hangzhou-based ClouDr Group Ltd (HKG: 9955), a one-stop chronic disease management and smart medical platform,...
Organon’s China Head Shi Wang Departs to Lead Sanofi Greater China
Women’s health specialist Organon (NYSE: OGN) announced the departure of its former China unit head...